PIA1/A2 gene polymorphism of platelet receptor IIb/IIIa and platelet aggregation activity in men after myocardial infarction occurred at an early age
- Authors: Berkovich O.A.1, Bazhenova E.A.1, Sirotkina O.V.2, Cherkashin D.V.3, Boitsov S.A.3, Shlyakhto E.V.1, Schwartz E.I.2
-
Affiliations:
- State Medical University
- Institute of Nuclear Physics RAS
- Russian Military-Medical Academy
- Issue: Vol 2, No 3 (2002)
- Pages: 42-48
- Section: Basis medicine
- Published: 29.08.2002
- URL: https://journals.eco-vector.com/MAJ/article/view/693533
- ID: 693533
Cite item
Abstract
We examined 212 men after myocardial infarction (MI) occurred before the age of 45, and 198 healthy men (control group). During the 2-year period 23 patients died of recurrent Ml.
Platelet aggregation was studied by G. V. R. Born’s and D. R. O’Brien’s method, PIA1/A2 glycoprotein (GP) IIb/IIIa gene polymorphism - by polymerase chain reaction (PCR) and subsequent restriction according to P. J. Neuman’s et al. method, plasma lipids - by enzymatic calorimetric method.
The level of PIA2 allele of GP IIb/IIIa was significantly higher in the study group than among controls (30,0 and 21,0 %, respectively; p=0,03). Among the dead patients the rate of PIA2 allele was significantly higher than among other patients (0,24 and 0,15, respectively; p=0,02). Maximal velocity of platelets aggregation was also higher in the patients with PIA2/A2 genotype than in those with PIA1 allele.
We conclude that the risk of MI in young men as well as the risk of sudden death of recurrent MI is higher in those with PIA2 allele of GP IIb/IIIa gene. This could be due to changes in platelet aggregation in patients with various genotypes of GP IIb/IIIa gene.
About the authors
O. A. Berkovich
State Medical University
Author for correspondence.
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg
E. A. Bazhenova
State Medical University
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg
O. V. Sirotkina
Institute of Nuclear Physics RAS
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg
D. V. Cherkashin
Russian Military-Medical Academy
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg
S. A. Boitsov
Russian Military-Medical Academy
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg
E. V. Shlyakhto
State Medical University
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg
E. I. Schwartz
Institute of Nuclear Physics RAS
Email: medaj@eco-vector.com
Russian Federation, St. Petersburg
References
- Киношенко Е. И. Тромбоцитарный гемостаз при инфаркте миокарда // Клиническая медицина. 1997. Т. 10. С. 21-27.
- Aleksic N., Juneja Н., Folsom A. R. et al. Platelet PI(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study // Circulation. 2000. Vol. 102. № 16. P. 1901-1905.
- Anderson J. L., King G. J., Bair T. L. et al. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. // J. Am. Coll. Cardiol. 1999. Vol. 33. № 3. P. 723-733.
- Ardissino D., Mannucci P. M., Merlini P. A. et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction // Blood. 1999. Vol. 94. № 1. P. 46-51.
- Feng D., Lindpaintner K., Larson M. G. et al. Platelet glycoprotein IIIа PIA polymorphism, fibrinogen, and platelet aggregability. The Framingham Heart Study // Circulation. 2001. Vol. 104. P. 140-144.
- Feng D., Lindpaintner K., Larson M. G. et al. Increased platelet aggregability associated with platelet GPIIIa P1A2 polymorphism. The Framingham Offspring study // Arterioscler. Thromb. Vase. Biol. 1999. Vol. 19. P. 1142-1147.
- Gardemann A., Humme J., Stricker J. et al. Association of the platelet glycoprotein IIIa P1A1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients // Thromb. Haemost. 1998. Vol. 80. №2. P. 214-217.
- Goodall A. H., Curzen N., Panesar M. et al. Increased binding of fibrinogen to glycoprotein IIIa-proline-33 (HPA-lb, PIA2, Zwb) positive platelets in patients with cardiovascular disease // Eur. Heart J. 1999. Vol. 20. P. 742-747.
- Kastrati A., Koch W. K., Gavaz M. et al. PIA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement // J. Am. Coll. Cardiol. 2000. Vol. 36. № 1. P. 84-89.
- Mamotte C. D. S., van Bockhmeer S. M., Tiylor R. R. P1A1/A2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis follow in coronary angioplasty//Am. J. Cardiol. 1998. Vol. 82. № 1. P. 13-35.
- Manzoli A., Andreotti F., Leone A. M. et al. Vascular and haemostasis gene polymorphisms associated with non-fatal myocardial infarction: A critical review // Ital. Heart J. 2000. Vol. 1. №3. P. 184-193.
- Merlini P. A., Ardissino D., Fetiveau R. et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. 1998. Abstract: 3229. Vienna, Austria.
- Metz E., Bernat I. S., Gonda F. Is the platelet glycoprotein IIb/IIIa PIA2 a risk factor in young patients suffering from myocardial infarction? 1998. Abstract: 1737. Rio de Jeneiro, Brazil.
- Michelson A. D., Furman M. I., Goldschmidt-Clermont P. Platelet GP IIIa PIA polymorphisms display different sensitivities to agonists // Circulation. 2000. Vol. 101. P. 1013-1018.
- Mikkelsson J., Perola M., Laippala P. et al. Glycoprotein IIIa PI(A1/A2) polymorphism and sudden cardiac death // J. Am. Coll. Cardiol. 2000. Vol. 36. №4. P. 1317-1323.
- Mikkelsson J., Perola M., Laippala P. et al. Glycoprotein IIIa PIA polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly // Arterioscler. Thromb. Vase. Biol. 1999. Vol. 19. P. 2573-2578.
- Mikkelsson J., Perola M., Penttilä A. et al. The GPIIIa (beta3-integrin) PIA polymorphism in early development of coronary atherosclerosis // Atherosclerosis. 2001. Vol. 154. №3. P. 721-727.
- Newman P. J., Derbes R. S., Aster R. H. The human platelet alloantigens PIA1 and PIA2 are associated with a leucine-33/proline-33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing // J. Clin. Invest. 1989. Vol. 83. № 5. P. 1778-1781.
- Nurden A. T. Polymorphism of platelet receptors as risk factors in coronary thrombosis // Eur. Heart J. 1996. Vol. 17. P. 1293-1294.
- O’Brien D. R., Heywood J. B., Heady J. A. The quantitation of platelet aggregation induced by four compounds: A study relation to myocardial infarction // Thromb. Haemorrh. 1966. Vol. 16. P. 725-767.
- Senti M., Aubo C., Bosch M. et al. Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators // Clin. Biochem. 1998. Vol. 31. № 8. P. 647-651.
- Thaulow E. C., Erikssen J., Sandbik L. et al. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men // Circulation. 1991. Vol. 84. P. 613-617.
- Topol E. J. Cardiology in the 21st century // Eur. Heart J. 2000. Vol. 2. Suppl. E. P. E18-E27.
- Vijayan К. V., Goldshmidt-Clermont P. J., Roos C., Bray P. F. The P1(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive function // J. Clin. Invest. 2000. Vol. 105. №6. P. 697-698.
- Weiss E. J., Bray P. F., Tayback M. et al. A polymorphism of platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis // New Engl. J. Med. 1996. Vol. 334. P. 1090-1094.
- Wu A. H., Tsongalis G. J. Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases //Am. J. Cardiol. 2001. Vol. 87. № Д2. P. 1361-1366.
- Zhu M. M., Weedon J., Clark T. Meta-analysis of the association of platelet glycoprotein IIIa PIA1/A2 polymorphism with myocardial infarction //Am. J. Coll. Cardiol. 2000. Vol. 86. № 1. P. 1000-1005.
- Zotz R. B., Winkelmann B. R., Nauck M. et al. Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen lb (HPA-1b/PIA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease. // Thromb. Haemost. 1998. Vol. 79. P. 731-735.
Supplementary files
